Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Symptoms prevalence in patients with gastrointestinal cancers : before versus after chemotherapy (CROSBI ID 493960)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Dobrila-Dintinjana, Renata ; Milić, Sandra ; Ružić, Alen ; Štimac, Davor Symptoms prevalence in patients with gastrointestinal cancers : before versus after chemotherapy // Gut. 2002. str. 51-51

Podaci o odgovornosti

Dobrila-Dintinjana, Renata ; Milić, Sandra ; Ružić, Alen ; Štimac, Davor

engleski

Symptoms prevalence in patients with gastrointestinal cancers : before versus after chemotherapy

Patients (pts) with gastrointestinal cancers suffer from many symptoms during their disease (1-25). Pain is the most prevalent symptom in cancer pts.Its occur in 70-90% of pts with advanced disease. Fatigue is the most frequently reported symptom in cancer patients undergoing chemotherapy (cht). The aim of this study was to compare the symptoms prevalence and its severity in cht naive pts versus after cht protocols were applied. 132 pts were inrolled into the study, there were 48 female and 74 male, with mean age of 64, 2 years.There were 86 (65, 1%) pts with metastatic or locally advanced disease. The most common cancer site was colorectal and pancreatic cancer. In follow-up period 264 cycles were applicated. Symptoms severity levels (mild, moderate, severe) had been evaluated in all pts at the start, after 1st and 2nd cycle of CPF (cisplatin, 5-fluorouracil and leucovorin) cht protocol. The most common symptoms reported in cht naive pts were pain in multiple sites (69, 7%), anorexia (53%), sleeping disorders (53%) and fatigue (47%). After 1st cycle of CPF cht, anorexia 56, 1%, fatigue 54, 5%, sleeping disorders 31, 8% and pain in 22, 7% pts were the most common symptoms. Fatigue 85, 6%, depression 58, 3%, anorexia 51, 5% and pain 17, 4% were the most reported symptoms after 2nd cycle of cht. With adequate analgetic therapy, pain become good controlled symptom, but fatigue experience during cht is a serious problem. Although CPF is middle toxic cht protocol, significant number of pts developed severe fatigue supporting the need for better fatigue management.

gastrointestinal cancers; symptoms; chemotherapy

Rad je kao poster prezentiran na istom skupu održanom od 19.-23.10.2002., Ženeva, Švicarska.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

51-51.

2002.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Gut

0017-5749

Podaci o skupu

United European Gastroenterology Week (10 ; 2002)

poster

01.01.2002-01.01.2002

Padova, Italija

Povezanost rada

Javno zdravstvo i zdravstvena zaštita

Indeksiranost